novel therapies for the treatment of nsclc: immunotherapy and targeted agents
Published 5 years ago • 59 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
3:24
novel immunotherapy agents on the horizon for lung cancer
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
2:20
selecting patients with nsclc who benefit from immunotherapy or targeted therapies
-
3:25
moving immunotherapy and targeted therapies to the frontline setting
-
1:22
recent advances in targeted agents for the treatment of lung cancer
-
2:53
immunotherapy and targeted therapy for advanced arcc
-
2:53
immunotherapy and targeted therapy for advanced arcc
-
0:47
combining radiotherapy with novel agents in nsclc
-
6:57
updates in lung cancer: neoadjuvant immunotherapy and targeted therapies
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc
-
3:41
targeted therapy versus standards of care in metastatic nsclc
-
2:07
targeted therapies for nsclc
-
5:43
novel immunotherapy combinations for sclc
-
1:19
developments in immunotherapy for lung cancer
-
5:40
immunotherapy and targeted therapies for melanoma
-
1:31
novel therapies for the treatment of bladder cancer
-
1:06
improving outcomes for patients with metastatic nsclc with immunotherapy
-
3:26
the impact of novel nsclc immunotherapies
-
0:58
novel immunotherapeutic strategies in lung cancer